Low Muscle Mass Is Associated with Readmission for Inflammatory Bowel Disease

Low Muscle Mass Is Associated with Readmission for Inflammatory Bowel Disease

Bibliographic Details
Main Authors:	Sifan Liu, Zibin Tian, Yueping Jiang, Xueli Ding, Shengbo Jin, Xue Jing
Format:	Article
Language:	English
Published:	AVES 2023-02-01
Series:	The Turkish Journal of Gastroenterology
Online Access:	https://www.turkjgastroenterol.org/en/low-muscle-mass-is-associated-with-readmission-for-inflammatory-bowel-disease-136972

Similar Items

Endoscopic ultrasound-guided drainage to abdominal abscess: A systematic review and meta-analysis
by: Sifan Liu, et al.
Published: (2022-01-01)

Differential metabolites in cirrhotic patients with hepatitis B and muscle mass loss
by: Xuechun Liu, et al.
Published: (2023-02-01)

Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease.
by: Dejan Micic, et al.
Published: (2017-01-01)

Sarcopenia and sarcopenic obesity in patients awaiting liver transplantation
by: Liang Fang, et al.
Published: (2023-09-01)

PHASE ANGLE AS A PREDICTOR OF MUSCLE MASS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
by: Angela Martinha BONGIOLO, et al.
Published: (2024-03-01)

The Impact of Incarceration on Readmissions Among Patients With Inflammatory Bowel Disease Hospitalized at a Community Hospital
by: Katherine M. Rich, et al.
Published: (2023-01-01)

Risk factors for 90-day readmission in veterans with inflammatory bowel disease—Does post-discharge follow-up matter?
by: Ashish Malhotra, et al.
Published: (2018-02-01)

A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis
by: Yueyi Xing, et al.
Published: (2022-12-01)

The Dietary Inflammatory Index Is Associated with Low Muscle Mass and Low Muscle Function in Older Australians
by: Marlene Gojanovic, et al.
Published: (2021-04-01)

Efficacy and safety of vedolizumab for pediatrics with inflammatory bowel disease: a systematic review
by: Shengbo Fang, et al.
Published: (2022-04-01)

Systematic review: Pelvic floor muscle training for functional bowel symptoms in inflammatory bowel disease
by: Angela J Khera, et al.
Published: (2019-12-01)

Circular RNAs in inflammatory bowel disease
by: Jie Lun, et al.
Published: (2023-12-01)

INFLAMMATORY BOWEL DISEASE AND SARCOPENIA: A FOCUS ON MUSCLE STRENGTH - NARRATIVE REVIEW
by: Joana MENDES, et al.
Published: (2023-09-01)

Low muscle mass in lung cancer is associated with an inflammatory and immunosuppressive tumor microenvironment
by: Sarah Santiloni Cury, et al.
Published: (2023-02-01)

Macrophage polarization in inflammatory bowel disease
by: Kun Zhang, et al.
Published: (2023-12-01)

Inflammatory bowel disease
by: Swiss Medical Weekly
Published: (2009-09-01)

INFLAMMATORY BOWEL DISEASE
by: I Gusti Ayu Mahaprani Danastri, et al.
Published: (2013-02-01)

Body mass index and bone mineral density by dexa in inflammatory bowel disease
by: Stroud, M, et al.
Published: (2001)

Dermatologic Manifestations in Inflammatory Bowel Disease
by: Hyun Yi Suh, et al.
Published: (2019-05-01)

The treatment of inflammatory bowel disease with monoclonal antibodies in Asia
by: Yu Chen, et al.
Published: (2023-01-01)

Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure
by: Olga Maria Nardone, et al.
Published: (2021-07-01)

Association between dietary inflammatory index and low muscle mass in diabetes/prediabetes patients
by: Wei Chen, et al.
Published: (2023-08-01)

Stem Cell-Based Therapies for Inflammatory Bowel Disease
by: Hua-Min Zhang, et al.
Published: (2022-07-01)

Inflammatory Bowel Disease in Asia: The Challenges and Opportunities
by: Pin-Jin Hu
Published: (2015-07-01)

Association of low muscle mass and combined low muscle mass and visceral obesity with low cardiorespiratory fitness.
by: Tae Nyun Kim, et al.
Published: (2014-01-01)

Ophthalmologic manifestations in patients with inflammatory bowel disease
by: Hye Jin Lee, et al.
Published: (2017-07-01)

The Role of Autophagy in Inflammatory Bowel Disease
by: Bo-Zong Shao, et al.
Published: (2021-02-01)

Low muscle mass, low muscle function, and sarcopenia in the urban and rural elderly
by: Sung Woo Moon, et al.
Published: (2022-08-01)

Bile Acid–Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside
by: Min Yang, et al.
Published: (2021-09-01)

Periodontitis and inflammatory bowel disease: a meta-analysis
by: Yang-yang She, et al.
Published: (2020-03-01)

Low Dietary Flavonoid Consumption Is Associated to Severe Inflammatory Bowel Disease
by: Beatrice Kölbel, et al.
Published: (2024-01-01)

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients
by: Mitchell R. K. L. Lie, et al.
Published: (2018-03-01)

Volatomics in inflammatory bowel disease and irritable bowel syndrome
by: Kathleen Van Malderen, et al.
Published: (2020-04-01)

The prevalence of radiographic sacroiliitis in patients affected by inflammatory bowel disease with inflammatory low back pain
by: M. Podswiadek, et al.
Published: (2004-06-01)

Mass cytometry reveals systemic and local immune signatures that distinguish inflammatory bowel diseases
by: Samuel J. S. Rubin, et al.
Published: (2019-06-01)

Catechins and Their Therapeutic Benefits to Inflammatory Bowel Disease
by: Fei-Yan Fan, et al.
Published: (2017-03-01)

Arthritis and inflammatory bowel disease.
by: Wordsworth, P
Published: (2000)

Salicylates for inflammatory bowel disease.
by: Travis, S, et al.
Published: (1994)

Cytokines and inflammatory bowel disease.
by: Radford-Smith, G, et al.
Published: (1996)

The immunology of inflammatory bowel disease.
by: Lowes, JR, et al.
Published: (1990)